Approvals/CIMA-AEMPS/ABILIFY MAINTENA 960 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA

Approved

STANDARD

ABILIFY MAINTENA 960 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA

Otsuka Pharmaceutical Netherlands B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 87966110ffdb1ca1
Drug Cima Aemps Name: ABILIFY MAINTENA 960 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA
Register Number: 113882010
Holder Company Name: Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name: Otsuka Pharmaceutical S.A.
Holder Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date: 2024-05-03
Dosage Form: SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADA EN JERINGA PRECARGADA
Dose: 960 mg
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v

ARIPIPRAZOL MONOHIDRATO

998,4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 3, 2024

Approval ID

87966110ffdb1ca1

Type

Standard